Skip to main content
    S

    Sionna Therapeutics, Inc. Common Stock (SION)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.12
    -0.21 (-6.31%)

    Market Cap: $150.63M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sionna Therapeutics, Inc. Common Stock (SION) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Sionna Therapeutics, Inc. Common Stock (SION) to earn -$2.59 per share in the fiscal year ending Dec 31, 2026. Of 12 analysts, 2 rate the stock Buy or Strong Buy, 10 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 2.83, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 17% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy216.7%
    Hold1083.3%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$2.59
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$2.29
    EPS consensus
    Next report
    Mar 1, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$2.59-$2.71 to -$2.507
    Dec 31, 2027-$2.29-$3.18 to -$1.2410

    Quarterly Estimates

    The EPS consensus rises from -$0.58 for the quarter ending Dec 31, 2026 to -$0.51 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.58-$0.78 to -$0.3313
    Mar 31, 2027-$0.51-$0.72 to -$0.415

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 8 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202621
    Fiscal year ending Dec 31, 202730
    Quarter ending Mar 31, 202730

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.56.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$2.59-$2.45-$2.45-$2.50-$2.56N/A
    Fiscal year ending Dec 31, 2027-$2.29-$2.23-$2.23-$2.52-$2.53N/A
    Quarter ending Mar 31, 2027-$0.51-$0.44-$0.44-$0.62-$0.62N/A

    Frequently Asked Questions About SION

    What is the SION stock forecast?

    Consensus analyst estimates put Sionna Therapeutics, Inc. Common Stock's EPS at -$2.59 for the fiscal year ending Dec 31, 2026. The consensus rating from 12 analysts is Hold.

    How do analysts rate SION stock?

    Of 12 analysts covering Sionna Therapeutics, Inc. Common Stock, 0 rate it Strong Buy, 2 Buy, 10 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from SION next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.59, with estimates from -$2.71 to -$2.50 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.29, with estimates from -$3.18 to -$1.24 from 10 analysts.

    How many analysts cover SION?

    12 analysts rate Sionna Therapeutics, Inc. Common Stock stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.